Clinical Efficacy Evaluation of First-in-class Imipridone ONC201 in Recurrent Type II Endometrial Cancer

Information

• Research Project
• 9769184

• ApplicationId

  9769184

• Core Project Number

  R44CA221398

• Full Project Number

  4R44CA221398-02

• Serial Number

  221398

• FOA Number

  PA-16-302

• Sub Project Id

• Project Start Date

  8/17/2017 - 7 years ago

• Project End Date

  8/31/2020 - 4 years ago

• Program Officer Name

  FRANCA-KOH, JONATHAN C

• Budget Start Date

  9/6/2018 - 6 years ago

• Budget End Date

  8/31/2019 - 5 years ago

• Fiscal Year

  2018

• Support Year

  02

• Suffix

• Award Notice Date

  9/6/2018 - 6 years ago

Organizations

• ONCOCEUTICS, INC.

IC Name

• Activity

  R44

• Administering IC

  CA

• Application Type

  4

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  714000

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  395

• Ed Inst. Type

• Funding ICs

  NCI:714000\

• Funding Mechanism

  SBIR-STTR RPGs

• Study Section

  ZRG1

• Study Section Name

  Special Emphasis Panel

• Organization Name

  ONCOCEUTICS, INC.

• Organization Department

• Organization DUNS

  830865312

• Organization City

  PHILADELPHIA

• Organization State

  PA

• Organization Country

  UNITED STATES

• Organization Zip Code

  191042619

• Organization District

  UNITED STATES